Use of recombinant human hyaluronidase to accelerate rapid insulin analogue absorption: experience with subcutaneous injection and continuous infusion.

Use of recombinant human hyaluronidase to accelerate rapid insulin analogue absorption: experience with subcutaneous injection and continuous infusion.

Item
http://www.wikidata.org/entity/Q37964354
Insulin delivery methods: Past, present and future[Fast-acting insulin - new developments towards more flexibility for the patient].Recommendations for Using Real-Time Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1 DiabetesClinical Immunogenicity of rHuPH20, a Hyaluronidase Enabling Subcutaneous Drug Administration.Insulin analogs for the treatment of diabetes mellitus: therapeutic applications of protein engineering.Pharmacokinetics and postprandial glycemic excursions following insulin lispro delivered by intradermal microneedle or subcutaneous infusion.Accelerating and improving the consistency of rapid-acting analog insulin absorption and action for both subcutaneous injection and continuous subcutaneous infusion using recombinant human hyaluronidaseUndeniable need for ultrafast-acting insulin: the pediatric perspectiveDesign of non-standard insulin analogs for the treatment of diabetes mellitusEnhanced absorption of insulin aspart as the result of a dispersed injection strategy tested in a randomized trial in type 1 diabetic patients.Ultrafast-acting insulins: state of the artMoving toward the ideal insulin for insulin pumps.Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiencyFaster pharmacokinetics and increased patient acceptance of intradermal insulin delivery using a single hollow microneedle in children and adolescents with type 1 diabetes.Recombinant Human PH20: Baseline Analysis of the Reactive Antibody Prevalence in the General Population Using Healthy Subjects.
P2860

Use of recombinant human hyaluronidase to accelerate rapid insulin analogue absorption: experience with subcutaneous injection and continuous infusion.

Item
http://www.wikidata.org/entity/Q37964354
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Use of recombinant human hyalu ...... ction and continuous infusion.
@en
Use of recombinant human hyalu ...... ction and continuous infusion.
@nl
type
label
Use of recombinant human hyalu ...... ction and continuous infusion.
@en
Use of recombinant human hyalu ...... ction and continuous infusion.
@nl
prefLabel
Use of recombinant human hyalu ...... ction and continuous infusion.
@en
Use of recombinant human hyalu ...... ction and continuous infusion.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Use of recombinant human hyalu ...... ction and continuous infusion.
@en
P2093
P304
P31
P356
P433
P478
P577
P698
P921